Full Text
Cost Per Response/Remission Across Biologics for the Treatment of Biologic Naïve Patients with Moderate-To-Severe Ulcerative Colitis from the Italian Healthcare Provider Perspective

Abstract

Authors

I Azzabi Zouraq L Fioravanti M Vernia

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×